Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04548635 · ClinicalTrials.gov registry record · Phase 2

VR for Burn Dressing Changes at Home

A Phase 2 study of Acute Pain and Burns, sponsored by Nationwide Children's Hospital.

Completed
Registry status
Phase 2
Development phase
36
Enrollment target
1
Study location

NCT04548635 is a Phase 2 study of Acute Pain and Burns that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 36 participants, below the 267-participant average among 50 other Acute Pain trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04548635, a Phase 2 study of Acute Pain and Burns, has completed, sponsored by Nationwide Children's Hospital.

COMPLETED
Registry status
Phase 2
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the impact of our smartphone-based Virtual Reality Pain Alleviation Tool (VR-PAT) during the repeated at-home burn dressing changes of children (5-17 years) with a burn injury in comparison with a control group of children with a burn injury who will not use VR-PAT during at-home burn dressing changes. We hypothesize that children using VR-PAT will report less pain during their dressing changes.

Interventions

  • DEVICE VR-PAT

Study Locations (1)

Ohio

  • Nationwide Children's Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2019-09-05
Est. Completion 2021-06-18
Phase Phase 2

Sponsor

Nationwide Children's Hospital

188 total trials

What the Registry Record Tells You About NCT04548635

The ClinicalTrials.gov registry entry for NCT04548635 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 50 other Acute Pain trials with a reported enrollment target (87% lower). The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Acute Pain appearing as the primary indexed condition, and to 1 intervention - of which VR-PAT is the first listed.

NCT04548635 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04548635 about?

NCT04548635 is a clinical study titled "VR for Burn Dressing Changes at Home". This study will evaluate the impact of our smartphone-based Virtual Reality Pain Alleviation Tool (VR-PAT) during the repeated at-home burn dressing changes of children (5-17 years) with a burn injury in comparison with a control group of children with a burn injury who will not use VR-PAT during at...

What is the current status of trial NCT04548635?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2019-09-05. Estimated completion is 2021-06-18.

What conditions does trial NCT04548635 study?

This clinical trial studies the following conditions: Acute Pain, Burns, Procedural Pain.

What interventions are being tested in trial NCT04548635?

The interventions under investigation include: VR-PAT (DEVICE).

Who is sponsoring clinical trial NCT04548635?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04548635 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.